Self-assembly of noncyclic bis-D- and L-tripeptides into higher order tubular constructs: Design, synthesis, and X-ray crystal superstructure

Journal of Organic Chemistry

Volumn 73, Issue 4, 2008, Pages 1181-1191

  Hanessian, Stephen ^a   Vinci, Valerio ^a   Fettis, Kamal ^a,b   Maris, Thierry ^a,b   Viet, Minh Tan Phan ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b Altana Pharma ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CRYSTAL STRUCTURE; HYDROGEN BONDS; MOLECULAR STRUCTURE; SOLVENTS; SYNTHESIS (CHEMICAL);

CHLOROFORM SOLVENT MOLECULES; OPEN-ENDED TUBULAR SUPERSTRUCTURE; X-RAY CRYSTAL SUPERSTRUCTURE;

PEPTIDES;

BENZENE; CHLOROFORM; CYCLOHEXANE DERIVATIVE; DIAMINE; TRIPEPTIDE DERIVATIVE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; DILUTION; HYDROGEN BOND; NUCLEAR MAGNETIC RESONANCE; PEPTIDE ANALYSIS; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SOLID STATE; STRUCTURE ANALYSIS; TITRIMETRY; TRANS ISOMER; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OLIGOPEPTIDES; PROTEIN CONFORMATION; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 39349109087     PISSN: 00223263     EISSN: None     Source Type: Journal    
DOI: 10.1021/jo701621c     Document Type: Article

References (69)

1. Petsko, G. A.; Ringe, D. In Protein Structure and Function; Sinauer Associates Inc.: Sunderland, MA, 2004; pp 49-83.
2. Lesk, A. M. In Introduction to Protein Architecture, The Structural Biology of Proteins; Oxford University Press: Oxford, 2000.
3. See for example, Alzheimers disease: (a) Rochet, J. C.; Lansbury, P. T. Curr. Opin. Struct. Biol. 2000, 10, 60-68.
4. (b) Baumeister, R.; Eimer, S. Angew. Chem., Int. Ed. 1998, 37, 2978-2982.
5. Huntington's disease: (c) Perutz, M. F. Curr. Opin. Struct. Biol. 1996, 6, 848-858.
6. (d) MacDonald, M. E.; Gusella, J. F. Curr. Opin. Neurobiol. 1996, 6, 638-643.
7. Prion protein disease: (e) Prusiner, S. B. Science 1997, 278, 245-251.
8. (f) Ng, S. B. L.; Doig, A. J. Chem. Soc. Rev. 1997, 26, 425-432.
9. See for example: (a) Betz, S. F.; Liebman, P. A.; DeGrado, W. F. Biochemistry 1997, 36, 2450-2458.
10. (b) Nautiyal, S.; Woolfson, D. N.; King, D. S.; Alber, T. Biochemistry 1995, 34, 11645-11651.
11. (c) Olofsson, S.; Johansson, G.; Baltzer, L. J. Chem. Soc., Perkin Trans. 2 1995, 11, 2047-2056.
12. (d) Ghadiri, R.; Soares, C.; Choi, C. J. Am. Chem. Soc. 1992, 114, 825-831.
13. For selected reviews, see: (a) Sanford, A. R.; Gong, B. Curr. Org. Chem. 2003, 7, 1649-1659.
14. (b) Cheng, R. P.; Gellman, S. H.; De Grado, W. F. Chem. Rev. 2001, 101, 3219-3232.
15. (c) Hill, D. J.; Mio, M. J.; Prince, R. B.; Hughes, T. S.; Moore, J. S. Chem. Rev. 2001, 101, 3893-4012.
16. (d) Cubberley, M.; Iverson, B. L. Curr. Opin. Chem. Biol. 2001, 5, 650-653.
17. (a) Hartgerink, J. D.; Clark, T. D.; Ghadiri, M. R. Chem. - Eur. J. 1998, 4, 1367-1372.
18. (b) Ghadiri, M. R. Adv. Mater 1995, 7, 675-677.
19. (a) Ghadiri, M. R.; Granja, J. R.; Milligan, R. A.; Mckee, D. E.; Khazanovich, N. Nature 1993, 366, 324-327.
20. (b) Hartgerink, J. D.; Granja, J. R.; Milligan, R. A.; Ghadiri, M. R. J. Am. Chem. Soc. 1996, 118, 43-50.
21. (c) Bong, D. T.; Clark, T. D.; Granja, J. R.; Ghadiri, M. R. Angew. Chem., Int. Ed. 2001, 46, 988-1011.
22. (d) Clark, T. D.; Buehler, L. K.; Ghadiri, M. R. J. Am. Chem. Soc. 1998, 120, 651-656.
23. (a) Rosenthal-Aizman, K.; Svensson, G.; Unden, A. J. Am. Chem. Soc. 2004, 126, 3372-3373.
24. (b) Amorin, M.; Castedo, L.; Granja, J. R. J. Am. Chem. Soc. 2003, 125, 2844-2845.
25. (c) Seebach, D.; Mathews, J. L.; Meden, A.; Wessels, T.; Baerlocher, C.; McCusker, L. B. Helv. Chim. Acta 1997, 80, 173-182.
26. Hodgson, D. R.; Sanderson, J. Chem. Soc. Rev. 2004, 33, 422-430.
27. For a recent review, see: Longhlin, W. A.; Tyndall, J. D. A.; Glenn, M. P.; Fairlie, V Chem. Rev. 2004, 104, 6085-6118.
28. For selected references, see: (a) Schrader, T.; Kirsten, C. Chem. Commun. 1996, 2089-2090.
29. (b) Kelly, J. W.; Lashuel, H. L.; La Brenz, S. R.; Woo, L.; Serpell, L. C. J. Am. Chem. Soc. 2000, 122, 5262-5277.
30. (c) Nowick, J. S.; Chung, D. M.; Maitra, K.; Maitra, S.; Stigen, K.; Sun, Y. J. Am. Chem. Soc. 2000, 122, 7654-7661.
31. (a) Das, A. K.; Haldar, D.; Hegde, R. P.; Shamala, N.; Banerjee, A. Chem. Commun. 2005, 1836-1838.
32. (b) Banerjee, A.; Maji, S. K.; Drew, M. G. B.; Haldar, D.; Banerjee, A. Tetrahedron Lett. 2003, 44, 335, 699-702.
33. (c) Haldar, D.; Maji, S. K.; Drew, M. G. B.; Banerjee, A.; Banerjee, A. Tetrahedron Lett. 2002, 43, 5465-5468.
34. (a) Haldar, D.; Banerjee, A.; Drew, M. G. B.; Das, A. K.; Banerjee, A. Chem. Commun 2003, 1406-1407.
35. (b) Ray, S.; Haldar, D.; Drew, G. D. B.; Banerjee, A. Org. Lett. 2004, 6, 4463-4465.
36. (a) Balaram, P. Curr. Opin. Struct. Biol. 1992, 2, 845-851.
37. (b) Karle, I. I.; Gurunath, R. B.; Prasad, S.; Kaul, R.; Rao, R. B.; Balaram, P. J. Am. Chem. Soc. 1995, 117, 9632-9637.
38. See for example: (a) Srinivasulu, G.; Kumar, S. K.; Sharma, G. V. M.; Kunwar, A. C. J. Org. Chem. 2006, 71, 8395-8400.
39. (b) Barsby, T.; Warabi, K.; Sørensen, D.; Zimmerman, W. T.; Kelly, M. T.; Andersen, R. J. J. Org. Chem. 2006, 71, 6031-6037.
40. (c) Görbitz, C. H. Chem. Commun. 2006, 2332-2334.
41. (d) Ray, S.; Haldar, D.; Drew, M. G. B.; Banerjee, A. Org. Lett. 2004, 6, 4463-4465.
42. (e) For a recent review, see: Moriuchi, T.; Hirao, T. Chem. Soc. Rev. 2004, 33, 294-301.
43. (f) Görbitz, C. H. Chem. - Eur. J. 2001, 7, 2332-2334.
44. Bennani, Y. L.; Hanessian, S. Chem. Rev. 1997, 97, 3161-3195.
45. Hanabusa, K.; Yamada, M.; Kimura, M.; Shirai, H. Angew. Chem., Int. Ed. Engl. 1996, 35, 1949-1950.
46. For details, see Supporting Information.
47. For selected examples of benzene inclusion in supramolecular complexes, see: (a) Hanessian, S.; Saladino, R.; Margarita, R.; Simard, M.; Chem. - Eur. J. 1999, 5, 2169-2183.
48. (b) Endo, K.; Sawaki, T.; Koyanagi, M.; Kobayashi, K.; Matuda, H.; Ayama, Y. J. Am. Chem. Soc. 1995, 117, 8341-8352.
49. (c) Collet, A. Tetrahedron 1987, 43, 5725-5729.
50. (d) Cerrini, S.; Giglio, E.; Mazza, F.; Pavel, N. Y. Acta Crystallogr., Sect. B 1979, 35, 2605-2609.
51. -3. For details, see Supporting Information.
52. Uppadine, L. H.; Keene, F. R.; Beer, P. D. J. Chem. Soc., Dalton Trans. 2001, 2188-2198.
53. (a) Wallace, B. A.; Ravikumar, K. Science 1988, 241, 182-187.
54. (b) Langs, D. A. Science 1988, 241, 188-191.
55. (c) Ketchen, R. R.; Hu, W.; Cross, T. A. Science 1993, 261, 1457-1460.
56. (d) Burkhart, B. M.; Li, N.; Langs, D. A.; Pangborn, W. A.; Duax, W. L. Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 12950-12955.
57. For relevant articles, see: (a) Åkerfelt, K.; Lear, L. D.; Wasserman, Z. R.; Chung, L. A.; De Grado, W. F. Acc. Chem. Res. 1993, 26, 191-197.
58. (b) Gokel, G. W.; Mukhopadhyay, A. Chem. Soc. Rev. 2001, 30, 274-286.
59. For a study of tartaric acid-gramicidin hybrids, see for example: (a) Stankovic, C. J.; Heinemann, S. H.; Schreiber, S. L. J. Am. Chem. Soc. 1990, 112, 3702-3704.
60. (b) Xiao, J.; Weisblum, B.; Wipf, P. J. Am. Chem. Soc. 2005, 127, 5742-5743.
61. Streinrauf, L. K.; Hamilton, J. A.; Sabesan, M. N. J. Am. Chem. Soc. 1982, 104, 4085-4091.
62. Hamada, T.; Matsunaga, S.; Yano, G.; Fusetani, N. J. Am. Chem. Soc. 2005, 127, 110-118.
63. (a) Sadowsky, J. D.; Murray, J. K.; Tomita, Y.; Gellman, S. H. ChemBioChem 2007, 8, 903-916.
64. (b) Price, J. L.; Horne, W. S.; Gellman, S. H. J. Am. Chem. Soc. 2007, 129, 6376-6377.
65. (c) Horne, W. S.; Price, J. L.; Keck, J. L.; Gellman, S. H. J. Am. Chem. Soc. 2007, 129, 4178-4180.
66. (d) Sadowsky, J. D.; Fairlie, W. D.; Hadley, E. B.; Lee, H.-S.; Umezawa, N.; Nikolovska-Coleska, Z.; Wang, S.; Huang, D. C. S.; Tomita, Y.; Gellman, S. H. J. Am. Chem. Soc. 2007, 129, 139-154.
67. (e) Porter, F. A.; Weisblum, B.; Gellman, S. H. J. Am. Chem. Soc. 2005, 127, 11516-11529.
68. For helical cation-promoted oligomeric, open-ended heterocycles, see: Petitjean, A.; Cuccia, A, L. A.; Lehn, J.-M.; Nierengarten, H.; Schmutz, M. Angew. Chem., Int. Ed. 2002, 41, 1195-1198.
69. Keizer, H. M.; Sijbesma, R. P. Chem. Soc. Rev. 2005, 34, 226-234.